ChemoGum

ChemoGum is a cannabinoid-based medicated chewing gum being developed by APIRx Pharmaceuticals for chemotherapy support, specifically targeting nausea and pain. As a small molecule cannabinoid formulation, it is designed to provide symptomatic relief for patients undergoing chemotherapy. The gum delivery system is intended to facilitate buccal absorption of the active cannabinoid(s), potentially offering a faster onset of action and improved bioavailability compared to traditional oral capsules, while also providing an easier administration route for patients suffering from severe nausea. The product is currently in the preclinical stage of development.

Brand names

ChemoGum